DAVITA INC. for DAVITA INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 19, 2021 | $1,080,000 | Replaced |
| 4th Quarter - Amendment | Apr 19, 2021 | $1,100,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Veterans VET
Issues related to Veterans Affairs and dialysis Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2021, provisions related to dialysis (no bill number) H.R. 133 Consolidated Appropriations Act, 2021, dialysis and kidney care issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAVIER DEJESUS BARAJAS MARTINEZ | — |
| KELLY PHILSON | — |
| JOELLE OISHI THORNHILL | — |
| LEANNE M ZUMWALT | — |
Medicare/Medicaid MMM
H.R. 8254 / S. 4574, Bringing Enhanced Treatments and Therapies to ESRD Recipients (BETTER) Kidney Care Act, all provisions CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to Chronic Kidney Disease and prevention Issues related to home dialysis Issues related to access to kidney transplantation for ESRD patients H.R. 3912 / S.1676, Chronic Kidney Disease Improvement in Research and Treatment Act of 2019, all provisions ESRD Treatment Choices (ETC) Mandatory Demonstration Worked with HHS and CMS on emergency response related to COVID-19 H.R. 5534/S. 3353 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020 H.R. 133 Consolidated Appropriations Act, 2021, dialysis and kidney care issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAVIER DEJESUS BARAJAS MARTINEZ | — |
| KELLY PHILSON | — |
| JOELLE OISHI THORNHILL | — |
| LEANNE M ZUMWALT | — |
Health Issues HCR
H.R. 8254 / S. 4574, Bringing Enhanced Treatments and Therapies to ESRD Recipients (BETTER) Kidney Care Act, all provisions CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to Chronic Kidney Disease and prevention Issues related to home dialysis Issues related to access to kidney transplantation for ESRD patients H.R. 3912 / S.1676, Chronic Kidney Disease Improvement in Research and Treatment Act of 2019, all provisions ESRD Treatment Choices (ETC) Mandatory Demonstration Worked with HHS and CMS on emergency response related to COVID-19 H.R. 5534/S. 3353 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020 H.R. 133 Consolidated Appropriations Act, 2021, dialysis and kidney care issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAVIER DEJESUS BARAJAS MARTINEZ | — |
| KELLY PHILSON | — |
| JOELLE OISHI THORNHILL | — |
| LEANNE M ZUMWALT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.